PSI-6206 10mg | ≥99%
CSNpharm
PSI-6206, the deaminated derivative of PSI-6130, is a selective inhibitor of HCV NS5B polymerase and the EC50 for inhibition of HCV replicon is > 100 μM.
More Information Supplier Page
PSI-6206, the deaminated derivative of PSI-6130, is a selective inhibitor of HCV NS5B polymerase and the EC50 for inhibition of HCV replicon is > 100 μM.
More Information Supplier Page
PSI-6206, the deaminated derivative of PSI-6130, is a selective inhibitor of HCV NS5B polymerase and the EC50 for inhibition of HCV replicon is > 100 μM.
More Information Supplier Page
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information Supplier Page
Ziprasidone HCl H2O is a full antagonist of D2 receptors and of 5-HT2A receptors and is a partial agonist of 5-HT1A receptors, of 5-HT2C receptors and 5-HT1D receptors, used as an atypical antipsychoticfor the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder.
More Information Supplier Page
Ziprasidone HCl H2O is a full antagonist of D2 receptors and of 5-HT2A receptors and is a partial agonist of 5-HT1A receptors, of 5-HT2C receptors and 5-HT1D receptors, used as an atypical antipsychoticfor the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder.
More Information Supplier Page
Closantel is a salicylanilide anthelmintic compound and exhibits different anthelmintic spectra and apparent toxicity in mammals.
More Information Supplier Page
Closantel is a salicylanilide anthelmintic compound and exhibits different anthelmintic spectra and apparent toxicity in mammals.
More Information Supplier Page
Closantel is a salicylanilide anthelmintic compound and exhibits different anthelmintic spectra and apparent toxicity in mammals.
More Information Supplier Page
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information Supplier Page
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
More Information Supplier Page